Consumer

ELEVAI Labs Unveils New Paradigm-Shifting Skincare Procedure to the American Society for Laser Medicine and Surgery (ASLMS)

ELEVAI Labs, a science-based, data-driven aesthetic skincare company, will launch its revolutionary core technology platform, PREx™ (Precision Regenerative Exosome Technology™),…

Read More »

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest stocks as well as news from…

Read More »

Chanson International Holding Announces Pricing of IPO

Chanson International Holding (NASDAQ: CHSN), a provider of bakery, seasonal, and beverage products through its chain stores in China and…

Read More »

5 Fintech Stocks To Capitalize On A Cashless Society

Investors looking to capitalize on this inevitable outcome have a number of options for companies to invest in. Below are…

Read More »

XTM Announces Launch of New Wage Incentive Program for North American Healthcare Workers

XTM Inc. (CSE: PAID) (OTCQB: XTMIF) (FSE: 7XT), a Miami and Toronto-based Fintech creator of disruptive payment innovations and staff…

Read More »

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest stocks as well as news from…

Read More »

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest stocks as well as…

Read More »

The End of an Era is Here For Netflix

On Wednesday, the streaming service began rolling out a system that charges fees for “extra member” sub-accounts when people outside…

Read More »

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest stocks as well as news from…

Read More »

How Mark Cuban’s Eponymous Drug Company is Disrupting the Multi-Billion Dollar U.S. Prescription Drug Industry

The company, founded by entrepreneur and billionaire investor Mark Cuban, operates on a cost-plus model, adding a small markup to…

Read More »
Back to top button
🔔
Stay Updated!
Get notifications for new content